June is Myasthenia Gravis Awareness Month: Spreading Rare Disease Awareness
source: pixabay.com

June is Myasthenia Gravis Awareness Month: Spreading Rare Disease Awareness

June is recognized as Myasthenia Gravis Awareness Month. Primarily organized by the Myasthenia Gravis Foundation of America (MGFA), this event is focused on spreading awareness as well as boosting efforts…

Continue Reading June is Myasthenia Gravis Awareness Month: Spreading Rare Disease Awareness
Phase 3 Clinical Trials Approved to Test SPI-1005 for Meniere’s Disease
RobinHiggins / Pixabay

Phase 3 Clinical Trials Approved to Test SPI-1005 for Meniere’s Disease

  According to a Town News press release, Sound Pharmaceuticals, a biopharmaceutical company based in Seattle, received FDA approval for their Phase 3 clinical trial on SPI-1005. The trial, STOPMD-3,…

Continue Reading Phase 3 Clinical Trials Approved to Test SPI-1005 for Meniere’s Disease
From “Survivor” to Surviving Hodgkin Lymphoma: How Ethan Zohn’s Log Challenge Raises Cancer Awareness
Photo by Thomas Peham on Unsplash

From “Survivor” to Surviving Hodgkin Lymphoma: How Ethan Zohn’s Log Challenge Raises Cancer Awareness

  Growing up, my family and I faithfully watched Survivor each week. Although my parents stopped watching a few years back, settling in every Wednesday during the season is somewhat of a…

Continue Reading From “Survivor” to Surviving Hodgkin Lymphoma: How Ethan Zohn’s Log Challenge Raises Cancer Awareness
Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation
source: pixabay.com

Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation

According to a story from BioSpace, the radiopharmaceutical company Clarity Pharmaceuticals has recently announced that the US Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation to its…

Continue Reading Experimental Treatment for Neuroblastoma Earns Rare Pediatric Disease Designation
Potential Treatment for Stomach Cancer Given Orphan Drug Designation
source: pixabay.com

Potential Treatment for Stomach Cancer Given Orphan Drug Designation

According to a story from BioSpace, the biopharmaceutical company MacroGenics, Inc. has just announced that the US Food and Drug Administration (FDA) has given Orphan Drug designation to the company's…

Continue Reading Potential Treatment for Stomach Cancer Given Orphan Drug Designation
FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis
source: pixabay.com

FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis

In a press release from Eli Lilly and Company, the company has announced recently that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (BLA)…

Continue Reading FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis
Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients
source: pixabay.com

Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients

Acadia Pharmaceuticals recently released the results of their Phase 3 trial of Nuplazid, a treatment for the psychosis that Parkinson's disease patients experience. This medication has been approved since 2016,…

Continue Reading Study: Nuplazid as a Treatment for Psychosis in Parkinson’s Disease Patients

Una Mutación SF3B1 Puede Causar un Nuevo Subconjunto de Síndromes Mielodisplásicos

La investigación genética es un campo floreciente y emocionante. Con el descubrimiento de nuevas mutaciones y variantes genéticas se llega a una comprensión más profunda de las enfermedades raras y…

Continue Reading Una Mutación SF3B1 Puede Causar un Nuevo Subconjunto de Síndromes Mielodisplásicos
Close Menu